Partnering

BioLume is seeking cash from either strategic partners or investors, or a combination of both, to fund the regulatory approval, manufacturing scale up, and commercialization of these proprietary bioluminescent proteins in BioLume’s exclusive field of use.  BioLume is prepared to exclusively license certain product and territory rights to various applications in the food, beverage and cosmetic fields to one or more companies to fund the company and develop the technology.  We are also looking for collaborators to develop various diagnostic imaging applications.

Business Strategy

Our business strategy has two components: 

We will add our natural bioluminescent proteins to various food, beverages and cosmetics products to make them “glow”. The options to accomplishing this include:

• developing “standard” formulations and colors of Lumoness™ that can be packaged and marketed separately by BioLume, or its partners, that would be added, by the consumer or business, to various food, beverage or cosmetic products of choice at the point of use
• developing “premixed” products, with partners, where Lumoness is integrated with a particular food, beverage or cosmetic product via either a delivery system or formulation.

Technically, either of these options is possible, and they are not mutually exclusive. The duration of Lumoness “glow” can vary by formulation, encapsulation, quantity used, host product, or delivery system.  The food, beverage and cosmetic uses will be the least expensive to develop and likely fastest to market due to regulatory treatment as a food additive.

Second, we will develop the diagnostic imaging applications of these proteins for anatomic, vascular, and molecular imaging.  We will pursue both grant and investor funding to develop the imaging applications.  Then, we may out-license imaging at a more advanced stage to a strategic partner.